Pub. Date : 2016 Mar
PMID : 26873495
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | In the large, randomized, double-blind, PARADIGM-HF trial, sacubitril/valsartan reduced the incidence of death from cardiovascular causes or first hospitalization for worsening heart failure (composite primary endpoint) significantly more than the angiotensin converting enzyme (ACE) inhibitor enalapril. | Valsartan | angiotensin I converting enzyme | Homo sapiens |